electroCore Welcomes New VP with Inducement Grant Announcement

electroCore Welcomes New Leadership with Inducement Grant

electroCore, Inc. (NASDAQ: ECOR), a prominent player in the bioelectronic medicine space, is excited to announce the addition of Thomas Freeburg as the Company's new VP, Corporate Controller, effective soon. This strategic move, set for November 11, comes as part of electroCore's ongoing commitment to enhance its management team and support its innovative approach to health and wellness.

Details of the Inducement Grant

The Compensation Committee of electroCore's Board of Directors has granted 5,000 restricted stock units (RSUs) to Mr. Freeburg in connection with his impending employment. These RSUs have been issued under NASDAQ Listing Rule 5635(c)(4), signalling the significance of Mr. Freeburg's role within the company. The grant will vest over three years, with one-third of the units becoming available on each anniversary of the grant. This structured vesting schedule not only aligns Mr. Freeburg's incentives with those of the company but also encourages longevity within the organization.

Innovative Bioelectronic Medicine Solutions

electroCore is committed to pioneering advancements in bioelectronic medicine, leveraging its non-invasive vagus nerve stimulation (nVNS) technology. This innovative platform is designed to enhance health outcomes and promote wellness. The company focuses on developing medical devices aimed at managing specific health conditions and improving wellness through consumer products during various stages of human performance and general wellbeing.

About electroCore, Inc.

As a commercial-stage bioelectronic medicine and wellness venture, electroCore is dedicated to developing and marketing products that help improve lives. Their mission revolves around harnessing cutting-edge medical technologies that provide non-invasive treatment options for patients while enhancing general health and wellbeing. Their dedication extends to both domestic and select international markets, showcasing a commitment to widespread accessibility and effectiveness.

Future Outlook and Initiatives

With Mr. Freeburg's addition to the team, electroCore is positioned to explore new avenues for growth and innovation. The management team anticipates leveraging Mr. Freeburg's expertise to enhance operations and spearhead initiatives that will further solidify the company's position as a leader in bioelectronic medicine.

Contact Information for Inquiries

For those seeking additional information about electroCore and its latest developments, the Company encourages reaching out to their dedicated investor relations team. Interested individuals can contact ECOR Investor Relations at (973) 302-9253 or via email at investors@electrocore.com.

Frequently Asked Questions

What is the role of Thomas Freeburg at electroCore?

Thomas Freeburg has been appointed as the VP, Corporate Controller at electroCore, effective November 11.

What are restricted stock units (RSUs)?

RSUs are a form of equity compensation, where employees receive shares of stock upon meeting certain vesting conditions.

How does electroCore utilize nVNS technology?

electroCore's nVNS technology is used to promote health and wellness through non-invasive stimulation of the vagus nerve.

What is the significance of NASDAQ Listing Rule 5635(c)(4)?

This rule allows companies to grant equity awards to new employees as an inducement to join the company.

How can I get more information about electroCore?

For more details, you can contact their investor relations team or visit their website for the latest updates.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.